HomepageAMED • NASDAQ
add
Amedisys Home Health and Hospice Care
Vorige slotkoers
$Â 91,90
Dag-range
$Â 91,68 - $Â 92,27
Jaar-range
$Â 82,17 - $Â 98,95
Beurswaarde
3,01Â mld. USD
Gem. volume
621,71K
Koers/winst
36,57
Dividendrendement
-
Primaire beurs
NASDAQ
In het nieuws
Financiële informatie
Resultatenrekening
Opbrengst
Netto inkomsten
(USD) | sep 2024info | Wijziging j-o-j |
---|---|---|
Opbrengst | 587,67Â mln. | 5,65% |
Bedrijfskosten | 203,11Â mln. | 2,88% |
Netto inkomsten | 16,91Â mln. | -34,86% |
Netto winstmarge | 2,88 | -38,33% |
Winst per aandeel | 1,00 | 2,04% |
EBITDA | 53,83Â mln. | 1,09% |
Effectief belastingtarief | 43,03% | — |
Balans
Totale activa
Totale passiva
(USD) | sep 2024info | Wijziging j-o-j |
---|---|---|
Contanten en kortetermijnbeleggingen | 245,45Â mln. | 214,23% |
Totale activa | 2,14Â mld. | 5,51% |
Totale passiva | 938,68Â mln. | 0,51% |
Totaal aandelenvermogen | 1,20 mld. | — |
Uitstaande aandelen | 32,75 mln. | — |
Koers-boekwaardeverhouding | 2,62 | — |
Rendement op activa | 5,52% | — |
Rendement op kapitaal | 7,07% | — |
Kasstroom
Nettomutatie in liquide middelen
(USD) | sep 2024info | Wijziging j-o-j |
---|---|---|
Netto inkomsten | 16,91Â mln. | -34,86% |
Operationele kasstroom | 105,62Â mln. | 1.173,09% |
Kasstroom uit beleggingen | -2,44Â mln. | -133,30% |
Kasstroom uit financiering | -15,09Â mln. | -141,24% |
Nettomutatie in liquide middelen | 88,09Â mln. | 613,81% |
Vrije kasstroom | 123,19Â mln. | 1.144,73% |
Over
Amedisys, Inc. is an American healthcare company based in Baton Rouge, Louisiana. They are one of the largest home health providers and second largest hospice care provider in the United States.
Amedisys provides in-home skilled nursing, physical therapy, occupational therapy and speech language pathology, medical social work, home aides, and hospice and bereavement services, with 11 million patient care visits in 2011.
Amedisys employs more than 21,000 individuals at more than 500 locations in 39 states and Washington, D.C. In 2010, annual revenues were approximately $1.6 billion. Amedisys was ranked 999 on the Fortune 1000 in 2011.
In June 2023, Optum agreed to acquire Amedisys for $3.3 billion. Wikipedia
Opgericht
1982
Hoofdvestiging
Website
Werknemers
19.000